About this document

Sun Pharma FDA 483 Observations 2025 by haroon is a document available to read on EtoBox.

The FDA conducted an inspection of Sun Pharmaceutical Industries Ltd. from June 2 to June 13, 2025, identifying multiple observations related to aseptic practices and contamination control. Key issues included improper handling of sterile products, lack of adequate environmental monitoring, and failure to follow established procedures to prevent microbiological contamination. The observations do not represent a final compliance determination, and the company is encouraged to address these issues and communi

Author

haroon

Language

EN